AEON
AEON
AMEX · N/A

Aeon Biopharma Inc

$1.16
+0.16 (+16.00%)
Financial Highlights (FY 2025)
Revenue
19.22M
Net Income
1.18M
Gross Margin
52.3%
Profit Margin
6.1%
Rev Growth
+20.2%
D/E Ratio
0.67
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 52.3% 52.3% 52.3%
Operating Margin 8.7% 8.0% 8.0%
Profit Margin 6.1% 5.7% 6.8%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 19.22M 20.30M 17.77M
Gross Profit 10.06M 10.62M 9.30M
Operating Income 1.67M 1.63M 1.43M
Net Income 1.18M 1.16M 1.21M
Gross Margin 52.3% 52.3% 52.3%
Operating Margin 8.7% 8.0% 8.0%
Profit Margin 6.1% 5.7% 6.8%
Rev Growth +20.2% +6.7% +16.3%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 7.62M 6.60M 7.98M
Total Equity 11.32M 11.40M 10.22M
D/E Ratio 0.67 0.58 0.78
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 2.01M 2.27M 2.16M
Free Cash Flow 1.07M 1.22M 952.2K